Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - TOTAL CURRENT ASSETS
Total Current Assets NBIX - Neurocrine Biosciences, Inc.
1.72 B
LAST VALUE
8.93%
2 YEAR CAGR
15.72%
5 YEAR CAGR
24.15%
10 YEAR CAGR